Cajal Neuroscience
Cajal Neuroscience, based in Seattle, specializes in drug discovery for neurodegenerative diseases, employing advanced technologies like high-throughput microscopy and multi-omics analyses.
Company Overview
Cajal Neuroscience is located at 1150 Eastlake Ave E, Ste 600/700, Seattle, WA 98109. The company is focused on drug discovery for neurodegenerative diseases. Encouraged by the pioneering work of Santiago Ramón y Cajal, who is considered the father of modern neuroscience, Cajal Neuroscience employs advanced techniques to identify and validate drug targets. They aim to transform target and drug discovery processes to address the complexities of neurodegeneration.
Technologies and Methods
Cajal Neuroscience utilizes high-throughput microscopy, functional genomics, and multi-omics analyses. These methods are integral to their drug target identification process. The company's approach includes combining human genetics with cutting-edge techniques such as next-generation sequencing and advanced imaging technologies. Additionally, they apply multi-omics methods and use multiplexed in vitro and in vivo screens to prioritize and validate genes associated with neurodegenerative diseases.
3D Neurodegeneration Visualization
One of the distinctive techniques employed by Cajal Neuroscience is lightsheet microscopy. This technology allows for 3D visualization of neurodegenerative processes in the brain. The high-resolution imaging capability provides detailed insights into the structural changes and disease progression at the cellular level, enhancing the understanding of neurodegenerative diseases.
Recent Funding and Investment
Cajal Neuroscience has successfully raised $96 million to support its mission of transforming target and drug discovery for neurodegeneration. The funding will be utilized to advance their innovative techniques and methodologies, furthering the progress in identifying effective treatments for neurodegenerative diseases.